Ronit Satchi‐Fainaro
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
Papers in
- Biomaterials 29
- Nanoparticle-Based Drug Delivery 26
- Oncology 54
- Cancer Cells and Metastasis 14
- Co-authors
- Doron ShabatEhud SegalAnat Eldar‐BoockAnna ScomparinRachel BlauGalia TiramPaula OfekEilam Yeini
- Journals
- Journal of Controlled Release (14 papers)Cancer Research (13 papers)Advanced Drug Delivery Reviews (7 papers)Bioconjugate Chemistry (7 papers)Journal of drug targeting (4 papers)
- Partner nations
- IsraelUnited StatesPortugal
In The Last Decade
Ronit Satchi‐Fainaro
151 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Biomaterials 1.9k
- Biomedical Engineering 2.6k
- Oncology 1.4k
- Molecular Biology 3.3k
- Pharmaceutical Science 289
Countries citing papers authored by Ronit Satchi‐Fainaro
This map shows the geographic impact of Ronit Satchi‐Fainaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronit Satchi‐Fainaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronit Satchi‐Fainaro more than expected).
Fields of papers citing papers by Ronit Satchi‐Fainaro
This network shows the impact of papers produced by Ronit Satchi‐Fainaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronit Satchi‐Fainaro. The network helps show where Ronit Satchi‐Fainaro may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronit Satchi‐Fainaro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 17 | |
| 4 | 2024 | 30 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 8 | |
| 9 | 2021 | 33 | |
| 10 | 2019 | 72 | |
| 11 | 2019 | 187 | |
| 12 | 2018 | 91 | |
| 13 | 2018 | 7 | |
| 14 | 2018 | 22 | |
| 15 | 2017 | 29 | |
| 16 | 2017 | 79 | |
| 17 | 2017 | 239 | |
| 18 | 2016 | 68 | |
| 19 | 2012 | 34 | |
| 20 | 2007 | 54 |
About Ronit Satchi‐Fainaro
Ronit Satchi‐Fainaro is a scholar working on Biomaterials, Oncology, Immunology and Allergy, Cancer Research and Biomedical Engineering, having authored 158 papers that have together received 7.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (41 papers), RNA Interference and Gene Delivery (32 papers), Nanoparticle-Based Drug Delivery (26 papers), Advanced biosensing and bioanalysis techniques (26 papers), Angiogenesis and VEGF in Cancer (16 papers), Immunotherapy and Immune Responses (16 papers), Cancer Cells and Metastasis (14 papers) and Dendrimers and Hyperbranched Polymers (12 papers). The work is most often cited by research in Biomaterials (1.9k citations), Biomedical Engineering (2.6k citations), Oncology (1.4k citations), Molecular Biology (3.3k citations) and Pharmaceutical Science (289 citations). Ronit Satchi‐Fainaro has collaborated with scholars based in Israel, United States and Portugal. Frequent co-authors include Doron Shabat, Ehud Segal, Anat Eldar‐Boock, Anna Scomparin, Rachel Blau, Galia Tiram, Paula Ofek, Eilam Yeini, Sabina Pozzi and Helena F. Florindo. Their work appears in journals such as Journal of Controlled Release, Cancer Research, Advanced Drug Delivery Reviews, Bioconjugate Chemistry and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.